STAT

Plastic tubes can’t save the lives of liver failure patients, and a biotech’s stock price plummets

Another effort by Vital Therapies to transform plastic tubes into a lifesaving artificial liver ended in disappointment.

Another effort by Vital Therapies () to transform into a lifesaving artificial liver ended in disappointment Wednesday. And after this latest setback, the

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
As Calls For Measles Vaccination Rise, It’s Crickets From The White House
President Trump has said nothing about the importance of vaccination in the midst of measles outbreaks — and health experts are divided on whether that's a good thing.
STAT2 min read
Ex-Theranos CEO Elizabeth Holmes To Return To Court In July To Set Possible Trial Date
A federal judge proposed a start date of July 8 for the blockbuster trial of ex-Theranos CEO Elizabeth Holmes and her former No. 2, Sunny Balwani.
STAT4 min readSociety
With Some Tweaks, CAR-T Cancer Therapy Could Be Made Safer — And More Widely Available — Study Suggests
With some tweaks, CAR-T #cancer therapy could be made safer — and more widely available — a new study suggests.